AstraZeneca, a British-based company, said that it was unfazed by the critics and that the Vioxx backlash would have no effect on its own consumer advertising for Nexium or other drugs.
The Government Accountability Office, an investigative arm of Congress, already has been asked to look into whether the FDA muzzled another staffer who linked antidepressants to raising the odds of children suffering suicidal tendencies.
With Vioxx coming off the pharmacy shelves, what is a patient who took that drug for pain supposed to do?
Pfizer's medical director, Dr. Gail Cawkwell, insisted that its drugs are safe.
Two newer arthritis drugs of the same type are waiting for marketing approval in the United States, but Miller said they will not be released without more review of their cardiovascular risks.
